Fig. 2From: Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort studyMagnitude of treatment effect. A Tumor response rates by subgroups (sex, age, mutation); B Best percentage change from baseline in the sum of volumes of target lesions in both groupsBack to article page